LIPO (Lipella Pharmaceuticals) Other Current Liabilities: $0.00 Mil (As of Sep. 2025)


LIPO Lipella Pharmaceuticals Inc LIPO
35 GF Score
Price $0.13
GF Value $8.69
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Lipella Pharmaceuticals Other Current Liabilities?

Lipella Pharmaceuticals LIPO 35 Other Current Liabilities is $0.00 Mil as of Sep. 2025. GuruFocus rates LIPO with a GF Score™ of 35/100 and a GF Value™ of $8.69 (Possible Value Trap). The stock has 1 warning sign investors should review.

Lipella Pharmaceuticals's other current liabilities for the quarter that ended in Sep. 2025 was $0.00 Mil.

Lipella Pharmaceuticals's annual other current liabilities stayed the same from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then declined from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($-0.00 Mil).

Lipella Pharmaceuticals Other Current Liabilities Related Terms

Lipella Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Lipella Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lipella Pharmaceuticals Other Current Liabilities Chart

Lipella Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
-0.00 0.00 0.00 0.00 -0.00

Lipella Pharmaceuticals Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 0.00 0.00
LIPO
35GF Score
Lipella Pharmaceuticals Inc LIPO
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lipella Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.00 Mil mean?
Lipella Pharmaceuticals (LIPO) has a Other Current Liabilities of $0.00 Mil as of Sep. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Lipella Pharmaceuticals.
Is Lipella Pharmaceuticals' Other Current Liabilities too high?
Lipella Pharmaceuticals' current Other Current Liabilities is $0.00 Mil. Overall, Lipella Pharmaceuticals has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lipella Pharmaceuticals' Other Current Liabilities compare to IOBTQ and WINT?
Lipella Pharmaceuticals' Other Current Liabilities of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Lipella Pharmaceuticals. Lipella Pharmaceuticals's current Other Current Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lipella Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lipella Pharmaceuticals (LIPO) is currently considered Possible Value Trap. The stock's GF Value™ is $8.69, compared to a current price of $0.13 — trading 98.5% below its estimated fair value. The current Other Current Liabilities is $0.00 Mil. Lipella Pharmaceuticals' overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Lipella Pharmaceuticals (LIPO), the current Other Current Liabilities is $0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lipella Pharmaceuticals (LIPO) Overvalued in 2026?

Based on GuruFocus' analysis, Lipella Pharmaceuticals stock appears to be undervalued. The current stock price of $0.13 is trading 98.5% below its estimated GF Value™ of $8.69. GuruFocus considers Lipella Pharmaceuticals to be Possible Value Trap.

Key valuation signals for LIPO:

  • Other Current Liabilities: $0.00 Mil
  • GF Value™: $8.69 vs. price of $0.13 (98.5% below fair value)
  • GF Score™: 35/100 with 1 warning sign

No single metric tells the full story. See the LIPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lipella Pharmaceuticals Business Description

Address 7800 Susquehanna Street, Suite 505, Pittsburgh, PA, USA, 15208
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
35GF Score

Get the complete analysis for LIPO

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price
$8.69
GF Value